Set, Ready, Afford: China Rushes To Access Innovation Amid New Drug Dash

 
• By Brian Yang

2018 is set to break the record for new drug approvals in China, which have included some immuno-oncology and powerful antiviral therapies. Providing access to these high-priced medicines to more patients in the populous country was high on the minds of several multinationals during a recent conference in Shanghai.

Payment Innovation increasingly important to new drug makers in China, a top topic at Shanghai conference, 12/1-2.
Payment Innovation Tops Executives' Agenda During Shanghai Conference • Source: Scrip

More from China

More from Focus On Asia